US Patent 10329357 Treatment of ocular disease
Patent 10329357 was granted and assigned to Aerpio Therapeutics on June, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10329357 Treatment of ocular disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.